Number of qualified sufferers: CDEC mentioned the uncertainty in the amount of clients with reasonably critical to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical gurus consulted by CADTH indicated that some patients who will be classified as having mild or average sickness can have a intense bleeding https://hemgenix84826.digiblogbox.com/60304133/a-secret-weapon-for-hemgenix